About us Contacts Interactions: 118 620
Drug search by name

Dactinomycin Intravenous and Myelosuppression

Result of checking the interaction of drug Dactinomycin Intravenous and disease Myelosuppression for safety when used together.

Check result:
Dactinomycin Intravenous <> Myelosuppression
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Severe and fatal myelosuppression, which may include neutropenia, thrombocytopenia and anemia, can occur with dactinomycin. If either the white blood cell or platelet count is markedly decreased, therapy with dactinomycin should be withheld or dose should be reduced to allow recovery. Therapy with dactinomycin should be administered cautiously in patients with myelosuppression. Close clinical monitoring of hematopoietic function is recommended.

References:
  • "Product Information. Cosmegen (dactinomycin)." Merck & Co, Inc, West Point, PA.
Dactinomycin Intravenous

Generic Name: dactinomycin

Brand Name: Cosmegen

Synonyms: Dactinomycin, DACTINomycin

Interaction with food and lifestyle
Drug interactions